These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26707628)

  • 1. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
    Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
    J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging.
    Jia Z; Geng D; Liu Y; Chen X; Zhang J
    J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases.
    Hatzoglou V; Tisnado J; Mehta A; Peck KK; Daras M; Omuro AM; Beal K; Holodny AI
    Cancer Med; 2017 Apr; 6(4):761-767. PubMed ID: 28303695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.
    Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A
    Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.
    You SH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST; Choi HJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Radiology; 2018 Mar; 286(3):981-991. PubMed ID: 29244617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
    Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
    Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of oligodendroglial and astrocytic tumors using imaging results: the added value of perfusion MR imaging.
    Yoon HJ; Ahn KJ; Lee S; Jang JH; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
    Neuroradiology; 2017 Jul; 59(7):665-675. PubMed ID: 28550465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grading of oligodendroglial tumors of the brain with apparent diffusion coefficient, magnetic resonance spectroscopy, and dynamic susceptibility contrast imaging.
    Naveed MA; Goyal P; Malhotra A; Liu X; Gupta S; Mangla M; Mangla R
    Neuroradiol J; 2018 Aug; 31(4):379-385. PubMed ID: 29469659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
    Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
    Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
    Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.
    Rochetams BB; Marechal B; Cottier JP; Gaillot K; Sembely-Taveau C; Sirinelli D; Morel B
    Neuroradiol J; 2017 Oct; 30(5):429-436. PubMed ID: 28556691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.
    Nguyen TB; Cron GO; Perdrizet K; Bezzina K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Sinclair J; Thornhill RE; Foottit C; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2017-22. PubMed ID: 26228886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.